Recognizing the duty of the Federal Government to lead the world in biomedical research.

Sponsor: Diana DeGette (Democratic-CO)

AI-generated ?

Report an error

Introduced

In Committee

Passed One Chamber

Passed Both Chambers

Signed into Law

Referred to the House Committee on Energy and Commerce.

House calls for doubling federal investment in medical research over the next decade.

A House resolution would declare that the U.S. government should boost its support for biomedical research. It calls for doubling federal investment over the next decade and protecting scientific decisions from political interference. This aims to speed up new treatments and improve health for all Americans.

What Would Change

Today, federal funding supports biomedical research, but the resolution claims past actions weakened this effort. If passed, this resolution would formally state the House's opinion that the government should protect and expand research, aiming to double investment over ten years and keep science free from political influence. This would lead to more medical breakthroughs and better health outcomes for Americans.

Key Provisions

Declares that U.S. biomedical research and development is a national asset that must be protected, improved, and expanded.
States that scientific decision-making in the Federal Government should be driven by evidence and free from political interference.
Recommends the Federal Government double its investment in biomedical research over the next decade.
Urges research to address major health issues like cancer, Alzheimer's disease, diabetes, and infectious diseases.
Calls for treating the federal biomedical research workforce with respect, good pay, and benefits.
States that Federal Government support is key to training new scientists and keeping top scientists in the U.S.

View on Congress.gov

HRES 601 · 119th Congress · AI Summary by gemini-2.5-flash · 10/10

Recognizing the duty of the Federal Government to lead the world in biomedical research.

What Would Change

Key Provisions

Lobbying Activity